|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Quinapril#Adult Indications and Dosage]] |
| {{Quinapril}}
| |
| {{CMG}}; {{AE}} {{AM}}
| |
| | |
| ==Indications And Usage==
| |
| | |
| ====Hypertension====
| |
| | |
| Accupril is indicated for the treatment of [[hypertension]]. It may be used alone or in combination with [[thiazide diuretics]].
| |
| | |
| ====Heart Failure====
| |
| | |
| Accupril is indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including [[diuretics]] and/or [[digitalis]].
| |
| | |
| In using Accupril, consideration should be given to the fact that another [[angiotensin-converting enzyme inhibitor]], [[captopril]], has caused [[agranulocytosis]], particularly in patients with renal impairment or [[collagen vascular disease]]. Available data are insufficient to show that Accupril does not have a similar risk.
| |
| | |
| ====Angioedema in black patients====
| |
| | |
| Black patients receiving ACE inhibitor monotherapy have been reported to have a higher incidence of [[angioedema]] compared to non-blacks. It should also be noted that in controlled clinical trials ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ACCUPRIL (QUINAPRIL HYDROCHLORIDE) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63cf5651-d52c-4d27-9fd4-ed9cd9724dff | publisher = | date = | accessdate = }}</ref>
| |
| | |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |